May 9, 2026 STAT+: Capricor Therapeutics accuses Nippon Shinyaku of slow-walking plans on Duchenne drug
April 26, 2026 FDA Grants Priority Review Vouchers for Psychedelic Drugs to Treat Depression and PTSD Under Trump Administration Plan